Protection of Mice against Lethal Staphylococcus Infection by Escherichia coli O86 Fractions

Area of Science:

• Immunology
• Microbiology
• Infectious Diseases

Background:

• Staphylococcus aureus is a significant human pathogen causing severe infections.
• Lipopolysaccharides (LPS) are key components of Gram-negative bacteria, like Escherichia coli.
• The role of specific bacterial components in modulating host defense against unrelated pathogens is an area of interest.

Purpose of the Study:

• To investigate the protective effects of protein-lipopolysaccharides and lipopolysaccharides from Escherichia coli O(86) against Staphylococcus aureus infection.
• To determine if these bacterial components can prevent mortality in a murine model.

Main Methods:

• Mice were infected intraperitoneally with a virulent strain of Staphylococcus aureus.
• Pre-treatment with small doses of protein-lipopolysaccharides and lipopolysaccharides from Escherichia coli O(86) was administered.
• Survival rates of infected mice were monitored.

Main Results:

• Administration of small doses of Escherichia coli O(86) protein-lipopolysaccharides and lipopolysaccharides significantly prevented mortality in mice infected with Staphylococcus aureus.
• The protective effect was observed against a clinically virulent strain of the pathogen.

Conclusions:

• Protein-lipopolysaccharides and lipopolysaccharides from Escherichia coli O(86) exhibit protective properties against Staphylococcus aureus infection in mice.
• These findings highlight a potential immunomodulatory role for bacterial components in combating heterologous infections.